Several rapid antigen tests for SARS-CoV-2 are in widespread use globally for COVID-19 diagnostics. They are believed to be useful in stopping the chain of transmission of the virus by providing the means to rapidly identify large numbers of cases as part of a mass-testing program. Following the emergence of VOC-202012/01, there was initially concern that rapid tests might not detect it, but Public Health England determined that rapid tests evaluated and used in the United Kingdom detect the variant.
SARS-CoV-2 Alpha variant
SARS-CoV-2 Omicron variant
SARS-CoV-2 Gamma variant
SARS-CoV-2 Beta variant
SARS-CoV-2 Kappa variant
SARS-CoV-2 Lambda variant
SARS-CoV-2 Mu variant
SARS-CoV-2 Delta variant